08.04.2020

MLC Medical Establishes Strategic Partnership with Instituto Biológico Argentino

MLC Medical LLC has entered into a strategic collaboration with Instituto Biológico Argentino S.A.I.C. (Biol), a specialized South American producer of high-precision hospital injectables.

The partnership brings three specialized critical care medicines to Georgia: Midatus® (Etomidate) for smooth hemodynamic induction of general anesthesia, Gasterina® (Octreotide) for endocrine and gastroenterological disorders, and Novopressina-V (Synthetic Vasopressin) for circulatory shock management and hemodynamic stability.

These additions fulfill important niches in operating rooms and intensive care units where cardiovascular stability and rapid physiological control are paramount.

MLC Medical is pleased to work with Instituto Biológico Argentino to make these critical care products readily available across the Georgian healthcare system.

კონტაქტი
MLC Medical Establishes Strategic Partnership with Instituto Biológico Argentino